AbstractA 56 year old retired theatre nurse who has metastatic breast carcinoma complains of reduced vision in the left eye since being started on Docetaxel (Taxotere), an oral anti-mitotic chemotherapeutic agent. Best corrected visual acuity was 6/18 in the left eye, and 6/9-1 in the right. Clinical examination and subsequent examination with optical coherence tomography and Intravenous Fluorescein angiography revealed evidence suggestive of drug related maculopathy. No abnormal findings were present in the right eye. As far as we are aware, this is the first reported case of maculopathy following commencement of Docetaxel with the absence of macular oedema
Copyright © 2015 Naoki Matsuoka et al.This is an open access article distributed under theCreativeCo...
Photo-recall phenomenon is a rarely recognized adverse event of chemotherapeutic agents. The physiop...
Docetaxel is a very effective chemotherapeutic agent for the treatment of metastatic or locally adva...
AbstractA 56 year old retired theatre nurse who has metastatic breast carcinoma complains of reduced...
BACKGROUND: Docetaxel is a chemotherapeutic agent of the taxane class of drugs for the treatment of ...
Paclitaxel is a member of the taxane agents that has demonstrated efficacy in ovarian cancer, both i...
Background: To describe the first reported case of toxic optic neuropathy secondary to docetaxel (Ta...
Background: To report the use of En-face optical coherence tomography (OCT) in a patient treated wit...
Paclitaxel is well known for its treatment effect on meta-static breast cancer. To date, various sid...
Cystoid macular edema (CME) is a rare side effect associated with chemotherapy. Although the develop...
Abstract Background Cystoid macular edema is a rare, vision-threatening side effect of the taxane fa...
AbstractPurposeWe describe a case of anterior necrotising scleritis secondary to Gemcitabine and Car...
Cystoid macular edema is rarely observed secondary to paclitaxel treatment. A 55-year-old female pat...
Background: Paclitaxel (PTX) is an antineoplastic drug widely used in treatments for ovarian, breas...
Abstract : Taxanes are widely used anticancer agents, produced from the plants of the genus Taxus (y...
Copyright © 2015 Naoki Matsuoka et al.This is an open access article distributed under theCreativeCo...
Photo-recall phenomenon is a rarely recognized adverse event of chemotherapeutic agents. The physiop...
Docetaxel is a very effective chemotherapeutic agent for the treatment of metastatic or locally adva...
AbstractA 56 year old retired theatre nurse who has metastatic breast carcinoma complains of reduced...
BACKGROUND: Docetaxel is a chemotherapeutic agent of the taxane class of drugs for the treatment of ...
Paclitaxel is a member of the taxane agents that has demonstrated efficacy in ovarian cancer, both i...
Background: To describe the first reported case of toxic optic neuropathy secondary to docetaxel (Ta...
Background: To report the use of En-face optical coherence tomography (OCT) in a patient treated wit...
Paclitaxel is well known for its treatment effect on meta-static breast cancer. To date, various sid...
Cystoid macular edema (CME) is a rare side effect associated with chemotherapy. Although the develop...
Abstract Background Cystoid macular edema is a rare, vision-threatening side effect of the taxane fa...
AbstractPurposeWe describe a case of anterior necrotising scleritis secondary to Gemcitabine and Car...
Cystoid macular edema is rarely observed secondary to paclitaxel treatment. A 55-year-old female pat...
Background: Paclitaxel (PTX) is an antineoplastic drug widely used in treatments for ovarian, breas...
Abstract : Taxanes are widely used anticancer agents, produced from the plants of the genus Taxus (y...
Copyright © 2015 Naoki Matsuoka et al.This is an open access article distributed under theCreativeCo...
Photo-recall phenomenon is a rarely recognized adverse event of chemotherapeutic agents. The physiop...
Docetaxel is a very effective chemotherapeutic agent for the treatment of metastatic or locally adva...